5,6,7,8-Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine derivatives as inhibitors of full-length RORγt
5,6,7,8-Tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine derivatives as inhibitors of full-length RORγt
复制标题
5,6,7,8-四氢苯并[4,5]噻吩并[2,3-d]嘧啶衍生物作为全长 ROR gamma t 抑制剂
DOI:
10.1016/j.bioorg.2019.103077
复制
发表时间:
2019-09-01
影响因子:
5.1
通讯作者:
Bai, Chuan
中科院分区:
文献类型:
--
作者:
Lao, Chuyu;Zhou, Xiaoqing;Bai, Chuan
Retinoid-related orphan receptor gamma-t (ROR gamma t) belongs to the nuclear receptor superfamily that takes vital roles in the development and maturation of T-helper 17 cell (Th17) and lymph-node genesis. Because Th17 cells have been proved to be major effectors in human autoimmune and inflammatory diseases, the agonists and antagonists of ROR gamma t have been discovered as promising leads for the therapeutics of these diseases. Most of the current studies of ROR gamma t inhibitors have been focused on ligand binding domain (LBD) of ROR gamma t because the structure and binding pockets of LBD have been elucidated and studied in detail. Recent research elucidated that the hinge domain (HD) of ROR gamma t was significantly involved in the SUMOylation of ROR gamma t and thus specifically affecting T cell development but not lymph-node genesis. These discoveries highlighted the potential of HD of ROR gamma t as the target of ROR gamma t inhibitors that could specifically inhibit Th17-related activities without affecting lymph-node genesis. In this study, we utilized a screening system with full-length ROR gamma t including DBD, HD and LBD to evaluate the activities of a synthesized library of tetrahydrobenzo[4,5]thieno[2,3-d]pyrimidine derivatives. We identified a potent lead compound (28) that effectively inhibited Th17 cell differentiation. Docking and structure-activity relationship (SAR) studies showed that compound 28 may not bind in the binding pocket as most of the known inhibitors, but may bind in the pocket closed to Gln223 and Leu244 in HD. Our studies showed evidence that the HD of ROR gamma t could afford a binding pocket for Th17 specific inhibitors and this domain should be further studied to discover potent and specific ROR gamma t inhibitors.